Last updated on 22 May 2025
Owner Info
GlaxoSmithKline Biologicals S.A.
Rue de l'Institut 89
B-1330 Rixensart, BELGIUM
Serial Number
2258432 filed on 4 Feb 2022
Correspondent
Legal Brand Protection Legal and Compliance GSK
79 New Oxford Street,
London WC1A 1DG,
UNITED KINGDOM
2258432
4 Feb 2022
4 Feb 2032
WORD
2 Nov 2021
BX
Status Date | Action Taken |
---|---|
22nd May 2025 | Amendment to International Registration Contact Requested |
2th Mar 2023 | Amendment to International Registration Contact Requested |
11th Jun 2022 | International Registration in Australia Protected correspondence sent |
10th Jun 2022 | IP Right Registration Published |
10th Jun 2022 | Status change to Registered/Protected |
3rd Apr 2022 | Application Accepted correspondence sent |
3rd Apr 2022 | IP Right has been Examined |
3rd Apr 2022 | IP Right Acceptance Published |
28th Mar 2022 | Status change to Accepted |
25th Mar 2022 | Examination expedited |